S-2150

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameS-2150
Drug Alias NameS-2150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersAdrenergic receptor alpha-1 antagonists
TargetsVoltage-gated calcium channelAdrenergic receptors alpha-1
Therapy Area/IndicationsHypertensionMyocardial InfarctionArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionMyocardial InfarctionArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A